Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion
Crossref DOI link: https://doi.org/10.1038/srep39355
Published Online: 2016-12-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Biaoxue, Rong
Hui, Pan
Wenlong, Gao
Shuanying, Yang
Text and Data Mining valid from 2016-12-15
Version of Record valid from 2016-12-15
Article History
Received: 26 September 2016
Accepted: 22 November 2016
First Online: 15 December 2016
Competing interests
: The authors declare no competing financial interests.